2025 年基於 NGS 的 RNA定序全球市場報告

預計未來幾年基於 NGS 的 RNA定序市場將呈指數級成長。到 2029 年，這一數字將成長至 104 億美元，複合年成長率為 25.2%。預測期內的成長歸因於臨床診斷、國際合作研究、倫理和監管框架、農業和環境研究以及綠色基因組學。預測期內的主要趨勢包括單細胞 RNA 定序（scRNA-seq）、空間轉錄組學、表觀轉錄組學、多組體學整合和永續農業。

精準醫療的擴張正在推動基於NGS的RNA定序市場的成長。精準醫療可協助醫療保健提供者制定客製化的治療計劃，並根據對患者病情的基因了解做出決策。精準醫療在治療癌症等嚴重方面受到越來越多的關注。基於 NGS 的 RNA定序有助於識別疾病的根本原因並推薦特定的精準治療方法。例如，根據美國非營利組織個人化醫療聯盟（PMC）2023年2月的報告，2021年新核准的新分子藥物（NME）中有35%是個人化藥物。 2022 年有 12 種新藥核准，過去八年一直佔新藥認證的四分之一以上，而十年前這一比例還不到 10%。隨著精準醫療的需求不斷成長，基於NGS的RNA定序的需求也將持續成長。

不斷擴張的製藥業預計將推動基於 NGS 的 RNA定序市場的未來成長。製藥業包括公共和私人組織對藥品和醫藥產品的發現、開發和生產。基於NGS的RNA定序正被用於透過深入分析基因表現、識別潛在藥物標靶、評估藥物反應和闡明疾病機制來更深入地了解分子過程，從而增強基因表現和開發。例如，2024年9月，美國ABA治療服務供應商Cross River Therapy發布的數據顯示，美國製藥業的銷售額為5,500億美元，2021年美國在藥物上的支出為5,769億美元。預計到 2025 年將從 6,050 億美元增加到 6,350 億美元。因此，製藥業的成長正在推動基於NGS的RNA定序市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球基於NGS的RNA定序PESTEL分析（政治、社會、技術、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球基於 NGS 的 RNA定序市場：成長率分析
• 全球基於 NGS 的 RNA定序市場表現：規模與成長，2019 年至 2024 年
• 全球基於 NGS 的 RNA定序市場預測：規模與成長，2024-2029 年，2034 年預測
• 全球基於 NGS 的 RNA定序總目標市場 (TAM)

第6章 市場細分

• 全球基於 NGS 的 RNA定序市場（依產品與服務、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 樣品製備產品
• 定序平台和耗材
• 定序服務
• 分析、儲存和管理資料
• 全球基於 NGS 的 RNA定序市場（按技術、性能和預測），2019 年至 2024 年，2024 年至 2029 年，2034 年
• 合成定序
• 離子半導體定序
• 單分子即時定序
• 奈米孔定序
• 全球基於 NGS 的 RNA定序市場（按應用、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 表達譜分析
• 小RNA定序
• 從頭轉錄組組裝
• 突變調用和轉錄組表觀遺傳學
• 全球基於 NGS 的 RNA定序市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 研究與學術
• 醫院和診所
• 製藥和生物技術公司
• 其他最終用戶
• 全球基於 NGS 的 RNA定序市場：樣品製備產品細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• RNA萃取試劑套件
• 文庫製備試劑套件
• 逆轉錄試劑套件
• 品管試劑
• 全球基於 NGS 的 RNA定序市場：按定序平台和耗材細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 定序設備
• 定序耗材
• 全球基於 NGS 的 RNA定序市場：定序服務細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 合約排序服務
• 自訂文庫製備服務
• 諮詢和實驗設計服務
• 全球基於 NGS 的 RNA定序市場：資料分析、儲存和管理細分市場，按類型、實際值和預測，2019-2024 年、2024-2029 年、2034 年
• 生物資訊軟體
• 資料分析服務
• 雲端基礎的資料儲存解決方案
• 資料管理平台

第7章 區域和國家分析

• 全球基於 NGS 的 RNA定序市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球基於 NGS 的 RNA定序市場：按國家/地區分類、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 基於 NGS 的 RNA定序市場：競爭格局
• 基於 NGS 的 RNA定序市場：公司簡介
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BGI Group Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• QIAGEN NV
• PerkinElmer Inc.
• Eurofins Scientific SE
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Hamilton Company
• Takara Bio Inc.
• Tecan Trading AG
• GENEWIZ Inc.
• Novogene Corporation
• Macrogen Inc.
• Zymo Research Corp.
• Lexogen GmbH
• Partek Incorporated
• GATC Biotech AG

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年基於 NGS 的 RNA定序市場：提供新機會的國家
• 基於 NGS 的 RNA定序市場 2029：細分市場將帶來新機會
• 基於 NGS 的 RNA定序市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

The NGS-based RNA sequencing market research report is one of a series of new reports from The Business Research Company that provides NGS-based RNA sequencing market statistics, including NGS-based RNA sequencing industry global market size, regional shares, competitors with a NGS-based RNA sequencing market share, detailed NGS-based RNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the NGS-based RNA sequencing industry. This NGS-based RNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The NGS-based RNA-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.23 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.

The NGS-based RNA-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.4 billion in 2029 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.

The expansion of precision medicine is propelling the growth of the NGS-based RNA sequencing market. Precision medicine assists healthcare providers in creating tailored treatment plans and making decisions based on a genetic understanding of the patient's condition. There is an increasing focus on precision medicines for addressing serious diseases such as cancer. NGS-based RNA sequencing is instrumental in identifying the underlying causes of diseases and recommending specific precision treatments. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently accounted for at least a quarter of new drug approvals over the past eight years, marking a substantial rise from less than 10% a decade ago. As the demand for precision medicines continues to grow, so too will the demand for NGS-based RNA sequencing.

The expanding pharmaceutical industry is anticipated to drive the growth of the NGS-based RNA sequencing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both public and private organizations. NGS-based RNA sequencing is utilized within this sector to conduct thorough analyses of gene expression, identify potential drug targets, evaluate drug responses, and comprehend disease mechanisms, thereby enhancing drug discovery and development through a better understanding of molecular processes. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, revealed that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medications in 2021. Projected spending is expected to rise to between $605 billion and $635 billion by 2025. Consequently, the growth of the pharmaceutical industry is propelling the expansion of the NGS-based RNA sequencing market.

A notable trend in the NGS-based RNA sequencing market is the formation of strategic partnerships. Companies are increasingly engaging in partnerships with NGS-based RNA sequencing firms to enter new markets and leverage collective resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA) partnered with multiple industry and academic collaborators to enhance diagnostic capabilities for respiratory RNA viruses. Such strategic partnerships contribute to bolstering the capacity to respond swiftly to public health emergencies and advance diagnostic capabilities.

Major companies in the NGS-based RNA-sequencing market are concentrating on innovative products to meet the growing demand for RNA sequencing. One such innovation is the development of ultra-fast RNA methods for molecular testing and life science research applications, offering exceptionally rapid RNA sequencing or analysis. In March 2022, Quantabio launched the sparQ RNA-Seq HMR Kit, an ultra-fast RNA library preparation tool designed for precision oncology applications. This kit enables the generation of high-quality NGS sequencer-ready libraries from intact or degraded samples in a single day.

In October 2022, Illumina Inc., a US-based company specializing in DNA sequencing and array-based technology, announced a collaboration with GenoScreen. This partnership seeks to enhance access to genomic testing for multidrug-resistant tuberculosis (MDR-TB), facilitating faster and more effective detection of drug resistance to aid in the global fight against TB, particularly in countries severely affected by the disease. GenoScreen is a France-based company focused on sequencing, genotyping, and bioinformatics.

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in NGS-based RNA sequencing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the NGS-based RNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
• 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
• 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly; Variant Calling and Transcriptome Epigenetics
• 4) By End User: Research & Academia; Hospitals & Clinics; Pharmaceutical & Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
• 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
• 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
• 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. NGS-Based RNA-Sequencing Market Characteristics

3. NGS-Based RNA-Sequencing Market Trends And Strategies

4. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global NGS-Based RNA-Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global NGS-Based RNA-Sequencing Market Growth Rate Analysis
• 5.4. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM)

6. NGS-Based RNA-Sequencing Market Segmentation

• 6.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Preparation Products
• Sequencing Platforms and Consumables
• Sequencing Services
• Data Analysis, Storage, and Management
• 6.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing
• 6.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expression Profiling Analysis
• Small RNA Sequencing
• De Novo Transcriptome Assembly
• Variant Calling and Transcriptome Epigenetics
• 6.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research & Academia
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users
• 6.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Extraction Kits
• Library Preparation Kits
• Reverse Transcription Kits
• Quality Control Reagents
• 6.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Instruments
• Sequencing Consumables
• 6.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Sequencing Services
• Custom Library Preparation Services
• Consultation And Experimental Design Services
• 6.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioinformatics Software
• Data Analysis Services
• Cloud-Based Data Storage Solutions
• Data Management Platforms

7. NGS-Based RNA-Sequencing Market Regional And Country Analysis

• 7.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific NGS-Based RNA-Sequencing Market

• 8.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China NGS-Based RNA-Sequencing Market

• 9.1. China NGS-Based RNA-Sequencing Market Overview
• 9.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India NGS-Based RNA-Sequencing Market

• 10.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan NGS-Based RNA-Sequencing Market

• 11.1. Japan NGS-Based RNA-Sequencing Market Overview
• 11.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia NGS-Based RNA-Sequencing Market

• 12.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia NGS-Based RNA-Sequencing Market

• 13.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea NGS-Based RNA-Sequencing Market

• 14.1. South Korea NGS-Based RNA-Sequencing Market Overview
• 14.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe NGS-Based RNA-Sequencing Market

• 15.1. Western Europe NGS-Based RNA-Sequencing Market Overview
• 15.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK NGS-Based RNA-Sequencing Market

• 16.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany NGS-Based RNA-Sequencing Market

• 17.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France NGS-Based RNA-Sequencing Market

• 18.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy NGS-Based RNA-Sequencing Market

• 19.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain NGS-Based RNA-Sequencing Market

• 20.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe NGS-Based RNA-Sequencing Market

• 21.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
• 21.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia NGS-Based RNA-Sequencing Market

• 22.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America NGS-Based RNA-Sequencing Market

• 23.1. North America NGS-Based RNA-Sequencing Market Overview
• 23.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA NGS-Based RNA-Sequencing Market

• 24.1. USA NGS-Based RNA-Sequencing Market Overview
• 24.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada NGS-Based RNA-Sequencing Market

• 25.1. Canada NGS-Based RNA-Sequencing Market Overview
• 25.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America NGS-Based RNA-Sequencing Market

• 26.1. South America NGS-Based RNA-Sequencing Market Overview
• 26.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil NGS-Based RNA-Sequencing Market

• 27.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East NGS-Based RNA-Sequencing Market

• 28.1. Middle East NGS-Based RNA-Sequencing Market Overview
• 28.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa NGS-Based RNA-Sequencing Market

• 29.1. Africa NGS-Based RNA-Sequencing Market Overview
• 29.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

• 30.1. NGS-Based RNA-Sequencing Market Competitive Landscape
• 30.2. NGS-Based RNA-Sequencing Market Company Profiles
  • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

31. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

• 31.1. QIAGEN N.V.
• 31.2. PerkinElmer Inc.
• 31.3. Eurofins Scientific SE
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. F. Hoffmann-La Roche Ltd.
• 31.6. Hamilton Company
• 31.7. Takara Bio Inc.
• 31.8. Tecan Trading AG
• 31.9. GENEWIZ Inc.
• 31.10. Novogene Corporation
• 31.11. Macrogen Inc.
• 31.12. Zymo Research Corp.
• 31.13. Lexogen GmbH
• 31.14. Partek Incorporated
• 31.15. GATC Biotech AG

32. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

34. Recent Developments In The NGS-Based RNA-Sequencing Market

35. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 NGS-Based RNA-Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 NGS-Based RNA-Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 NGS-Based RNA-Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer